Inactive Instrument

Transcripts Reshape Lifesciences Inc Nasdaq

Equities

US7611231082

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024	Apr. 01
Transcript : ReShape Lifesciences Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Transcript : ReShape Lifesciences Inc., Q2 2023 Earnings Call, Aug 07, 2023	23-08-07
Transcript : ReShape Lifesciences Inc., Q1 2023 Earnings Call, May 15, 2023	23-05-15
Transcript : ReShape Lifesciences Inc., 2022 Earnings Call, Apr 25, 2023	23-04-25
ReShape Lifesciences Inc. Provides Revenue Guidance	22-11-14	CI
Transcript : ReShape Lifesciences Inc., Q3 2022 Earnings Call, Nov 14, 2022	22-11-14
Transcript : ReShape Lifesciences Inc., Q2 2022 Earnings Call, Aug 15, 2022	22-08-15
Transcript : ReShape Lifesciences Inc., Q1 2022 Earnings Call, May 23, 2022	22-05-23
Transcript : ReShape Lifesciences Inc., Q4 2021 Earnings Call, Mar 28, 2022	22-03-28
Transcript : ReShape Lifesciences Inc., Q3 2021 Earnings Call, Nov 11, 2021	21-11-11
Transcript : ReShape Lifesciences Inc., Q2 2021 Earnings Call, Aug 16, 2021	21-08-16
Transcript : Obalon Therapeutics, Inc. - Shareholder/Analyst Call	21-05-25
Transcript : ReShape Lifesciences Inc., Q1 2021 Earnings Call, May 18, 2021	21-05-18
Transcript : ReShape Lifesciences Inc., Q4 2020 Earnings Call, Mar 10, 2021	21-03-10
Transcript : ReShape Lifesciences Inc., Q3 2020 Earnings Call, Nov 12, 2020	20-11-12
Transcript : ReShape Lifesciences Inc., Q2 2020 Earnings Call, Aug 13, 2020	20-08-13
Transcript : ReShape Lifesciences Inc., Q4 2019 Earnings Call, Mar 26, 2020	20-03-26
Transcript : Obalon Therapeutics, Inc., Q4 2019 Earnings Call, Feb 27, 2020	20-02-27
Transcript : ReShape Lifesciences Inc., Q3 2019 Earnings Call, Nov 14, 2019	19-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Reshape Lifesciences Inc Nasdaq

Equities

US7611231082

Transcripts

Filters